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Abstract
Purpose The aim of our study was to evaluate treatment
results and toxicity of stereotactic irradiation for arteriove-
nous malformations (AVMs) in children.
Methods A group of ten consecutive children (four boys and
six girls) irradiated between 2002 and 2010 at our institution
was included into the study. The mean age at the time of
treatment was 15.4 and ranged between 8 and 18 years.
There were two Spetzler–Martin grade IV, four grade III,
and four grade II lesions. Mean AVM volume was 13.2 cm3
and varied from 0.6 to 36.8 cm3. In five patients, the
planned dose of 16–20 Gy was delivered in single fraction,
in five the total dose of 16–24 Gy was delivered in two to
three fractions. One patient was reirradiated with a dose of
15 Gy, 7 years after the initial treatment.
Results The median follow-up was 38.5 months. The treat-
ment resulted in total obliteration in eight patients and
partial in one. The median time to obliteration was
22 months; actuarial total obliteration rates were 20, 54,
54, and 83 % after 1, 2, 3, and 4 years of follow-up,
respectively. No patient bled after the treatment. In one
patient, new epileptic seizures developed after the treatment;
in magnetic resonance imaging, focal necrosis was revealed.
In five patients, asymptomatic imaging abnormalities were
seen during follow-up.
Conclusions Stereotactic radiotherapy appears to be an
effective method of treatment for pediatric AVMs, the
patients however require meticulous follow-up because
of relative high incidence of radiation-induced imaging
abnormalities.
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Introduction
Arteriovenous malformations (AVMs) are considered con-
genital lesions of the brain. They are however diagnosed
mainly in patients at their 30s or 40s, whereas the incidence
in children is lower. Angiogenic potential of AVMs in chil-
dren can be responsible for systematic growth of the lesions
during childhood and adolescence and is proposed to be one
of the reasons of relatively low number of lesions diagnosed
at young age [17, 23, 37]. The intensity of angiogenesis
seems to decrease over time and probably is negligible in
the mature organism. There is however some evidence that
certain factors, like the material used for embolization or
transient hypoxia caused by the procedure itself, can stimu-
late angiogenesis in otherwise mature AVMs [2, 39].
There is still a widespread opinion that the mainstay of
the treatment is microneurosurgical removal of the AVM.
There is however an increasing number of evidence that
stereotactic radiosurgery can be considered as a primary
treatment modality in children and the number of
treatment-related complications can be even lower than in
adults [30]. Usually, the lesions that cannot be surgically
removed are treated with embolization or stereotactic radio-
surgery often associated with endovascular procedures [24].
Embolization in certain cases however may result with
subtotal occlusion of the nidus leaving some portions of
the lesion connected to the circulation and thus, posing a
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risk of rupture [26, 35]. Nevertheless, curative embolization
can be attempted with good results in carefully selected
patients with small- or intermediate-sized AVMs [42].
The treatment of arteriovenous malformations in children
is a special challenge. Not only due to angioproliferative
potential of the lesion which can attenuate the results of the
treatment but also due to higher risk of bleeding than in
adults, substantial death rate, and potential late sequelae of
the treatment [22, 28, 43]. There are also concerns that
exposure of the immature brain to ionizing radiation can
affect the intellectual abilities or cause neurological damage
[43]. Moreover, AVMs in children are more often localized
in deep structures or eloquent regions of the brain than in
adults which makes the surgical treatment more difficult or
even impossible.
Discussing the indications for radiosurgery of AVMs in
children, it is important to note that death rate due to cere-
bral hemorrhages in children is very high and ranges be-
tween 6 and 38 % according to various sources [4, 6, 40].
AVM rupture is one of the most frequent reasons of hemor-
rhagic stroke in children and is responsible for 14–56 % of
all strokes in this age group [4, 6, 10, 12, 16, 40]. Cumula-
tive risk of bleeding from an AVM can be calculated from
the Brown formula and is directly associated with age of the
patient [7]. It means that AVM diagnosed in a child almost
inevitably leads to and intracranial hemorrhage (ICH), and
thus, should be treated. The available choices are micro-
neurosurgery, stereotactic radiosurgery, and embolization.
Sometimes satisfactory results can be obtained only with a
combination of two or even three methods.
In this report, we review our experience with linear
accelerator-based radiosurgical treatment of pediatric
AVMs. We focus on obliteration rate, prevention of intra-
cranial hemorrhage, side effects of the treatment, and
radiation-induced alterations in imaging studies.
Material and methods
A group of ten consecutive children (four boys and six girls)
irradiated between 2002 and 2010 at our institution is ana-
lyzed in the current study. The mean age at the time of
treatment was 15.4 and ranged between 8 and 18 years.
There were two Spetzler–Martin grade IV, four grade III,
and four grade II lesions. The mean AVM volume was
13.2 cm3 and ranged between 0.5 and 36.8 cm3. For all
lesions, the modified radiosurgery-based AVM score de-
fined as AVM score00.1×AVM volume+0.02×patient’s
age+0.3×location (location is a two-tiered variable and
has a value of 1 for lesions located in thalamus, basal
ganglia, and brainstem; for other locations, the value is 0)
was calculated [33]. The mean and median modified
radiosurgery-based AVM score was 1.69 and 1.7,
respectively, and ranged between 0.41 and 4.26. All AVMs
were located supratentorially, three of them intra- or peri-
ventricularly. Six patients presented with hemorrhage, three
with epileptic seizures, and one only with impaired con-
sciousness. One patient had bled twice before the treatment
was started. Two had symptoms of hemiparesis after ICH.
One patient underwent a surgical procedure (subtotal re-
moval of the nidus) before irradiation. We decided to in-
clude in this report patients treated both with stereotactic
radiosurgery and hypofractionated stereotactic radiotherapy
because of low number of children irradiated for cerebral
AVMs and in order to allow direct comparison of the two
fractionation regimens. The clinical and treatment character-
istics of each patient are presented in detail in Table 1 in
order to facilitate potential future meta-analysis of the
results of stereotactic irradiation of pediatric AVMs.
All patients were irradiated with a linear accelerator with
a micro-multileaf collimator used for field shaping. The
head was immobilized in a thermoplastic mask designed
for stereotactic treatment and a relocatable stereotactic frame
was used in all cases to define external coordinates. Treat-
ment planning was based on computed tomography per-
formed with the relocatable stereotactic frame, magnetic
resonance (MR), and magnetic resonance angiography
images. In no case anesthesia was required. The dose was
specified at the isocenter and the planning was optimized to
encompass the lesion with 95 % isodose. In case of lesions
adjacent to organs at risk, like the optic pathway or brain-
stem, a focal drop to 90 % of the prescribed dose was
accepted. In five patients, the planned dose of 16–20 Gy
was delivered in a single fraction, in five the total dose of
16–24 Gy was delivered in two to three fractions. One
patient was reirradiated with a dose of 15 Gy, 7 years after
the initial treatment. Apart from the use of stereotactic
frame, the correct position of the patient was additionally
verified with the on-board imaging device immediately be-
fore irradiation to account for possible positioning inaccu-
racies that may occur when stereotactic mask and
relocatable frame are used instead for invasively fixated
stereotactic frame. Actuarial obliteration rates were calcu-
lated with Kaplan–Meier method. Due to small number of
patients in our series, subgroup comparisons were made
with Fisher’s exact test for small samples.
Results
The median follow-up time was 38.5 months and ranged
from 13 to 120 months. The treatment resulted in total
obliteration in eight patients and partial in one; in one, no
response to treatment was seen. One patient was irradiated
twice because of incomplete obliteration after the first pro-
cedure. The second treatment was performed 7 years after
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the first irradiation and resulted with total obliteration of the
nidus. The median time to obliteration was 22 months.
Crude total obliteration rate was 80 %. Actuarial total oblit-
eration rates were 20, 54, 54, and 83 % after 1, 2, 3, and
4 years of follow-up, respectively. Crude response rate (total
and partial obliterations) was 90 %. Actuarial treatment
response rates were 20, 54, 65, and 89 % after 1, 2, 3, and
4 years of follow-up, respectively. The only patient who did
not respond to the treatment had the largest lesion
(36.8 cm3) and was irradiated with 16 Gy delivered in two
fractions because of the size of the nidus and critical loca-
tion, adjacent to the brainstem and optic pathway. In this
patient, reirradiation of the nidus is considered.
No patient bled during 42.5 patient-years of observation;
therefore, bleeding risk after treatment could not be reliably
calculated. In one patient, new epileptic seizures developed
after the treatment. MR imaging revealed symptoms of
demyelination around the irradiated nidus. The seizures
gradually resolve and currently she experiences only an aura
in approximately every 6 months. In one patient, after the
second treatment, an asymptomatic focal necrosis was
revealed on MRI which partially resolved after another year
of follow-up.
In five patients, asymptomatic imaging abnormalities
were seen during follow-up. The imaging abnormalities
were defined as T2 or FLAIR hyperintensity or T1 hypo-
intense areas. Due to low number of patients in the study, no
detailed statistical calculations could be made. According to
results of the Fisher’s exact test, no apparent dependence of
obliteration on AVM volume, Spetzler–Martin grade (2 vs.
>2), dose (<20 vs. ≥20 Gy), or AVM score (<1.7 (median
value) vs. ≥1.7) could be identified. Both single fraction
treatment and hypofractionated stereotactic radiotherapy
resulted with comparable number of obliterations (p00.33
and p00.6 for total and total + partial obliterations, respec-
tively, Fisher’s exact test). Similarly, no apparent association
of the dose, fractionation regimen, and volume irradiated
and the incidence of imaging abnormalities could be seen.
Discussion
This is a series of ten children irradiated for cerebral AVMs
with crude obliteration rate of 80 % and no bleeding ob-
served after the treatment. Hemorrhage form a ruptured
AVM is the most frequent symptom leading to the diagnosis
of the malformation both in adults and children [19]. Nev-
ertheless, both death rate and the risk of permanent neuro-
logical sequelae are higher in children [5, 9]. These data
show that the potential risk associated with exposition of the
immature organism for ionizing radiation is overcome by
expected elimination of the risk of bleeding. In our series, no
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the results reported by Nicolato et al. and compares favor-
ably with other series reporting the annual bleeding hazard
rate of 1.3–4.7 %, to even 9.1 % in the first and 13.6 % in
the second year of follow-up [8, 22, 29, 31, 44]. According
to the literature, malformations in the posterior fossa are of
special concern because the risk of death following rupture
can approach 42–57 % and that location is much more
frequent in children than in adults [15, 21, 27, 34]. In our
series, no lesion was localized in the infratentorial space. It
can be explained by selection bias resulting from relative
low number of children referred to radiosurgery for AVMs
in our country and limited number of patients included into
the study.
Crude total obliteration rate of 80 % in our series is
among the highest of reported by other authors [8, 18, 22,
31, 32, 36, 44]. Better results can be obtained by applying
higher doses but this carries a risk of increasing the compli-
cation rate. Doses of 24–25 Gy specified on the surface of
the lesion allow for obliteration rate approaching 100 % but
at the cost of unacceptable risk of serious complications. In
the series published by Mirza et al., the incidence of adverse
effects after delivery of 24–25 Gy in single fraction was as
high as 50 % [28]. Actuarial obliteration rate was stable in
the second and third year of follow-up; this phenomenon
however can be explained as a statistical artifact resulting
from low number of patients in our series.
Total obliteration is considered the ultimate goal of radio-
surgery for cerebral AVMs. Nevertheless, literature data
indicate that subtotally obliterated malformations possess a
negligible risk of bleeding and eventually obliterate in most
cases [22]. In our opinion, the primary goal of radiosurgery
should be elimination of the risk of bleeding but not neces-
sarily complete obliteration without early draining veins on
angiography. Pertinent aiming at complete radiological
obliteration by application of higher doses increases the risk
associated with the treatment without apparent profits for
the patient because the risk of hemorrhage is not further
reduced in a significant way [1, 22].
The probability of obliteration was not directly associated
with the fractionation regimen. Both single fraction treat-
ment and hypofractionated stereotactic radiotherapy yielded
comparable rates of obliterations. Satisfactory results of
hypofractionation in children could be associated with bio-
logical features of an immature AVM. Higher mitotic and
metabolic activity of the cells can possibly result with faster
and more efficient production of myofibroblasts responsible
for subsequent obliteration of the nidus. This can be true
even after stimulation with lower single doses, assuming
that fraction dose is sufficient for triggering the effect and
total dose applied is within the therapeutic range. There is
some evidence that younger patients respond better to radio-
surgery, not only when comparing children and adult popu-
lation, but even if we consider only the group of pediatric
patients [31, 34, 36]. The difference in biological features
between adult and pediatric AVMs was already proposed in
the literature and confirmed in recent studies, but the exact
reason of the specific behavior of the pediatric AVMs is still
to be explained [25, 31]. Vascular proliferation and expres-
sion of VEGF and its receptors observed in AVMs, de novo
formation of the lesions, and low prevalence of AVMs in
infants suggest that these lesions in young age can have
greater mitotic potential resulting with greater alpha/beta
ratio than that reported in the adult population [3, 11, 13,
17, 23, 38, 39]. Estimations of alpha/beta ratio for AVMs
yielded the value of 1.2–3.5 Gy, characteristic for non-
proliferating, late responding tissues [20]. Analysis of
smaller lesions however suggested that they can respond
somewhat different and the alpha/beta ratio can approach
5–6 Gy which can be the rationale for hypofractionated
regimens [20]. If pediatric AVMs present similar propensi-
ties, higher obliteration rates than in adults after hypofrac-
tionated stereotactic radiotherapy can be expected. This
hypothesis of course is of very speculative nature and its
confirmation requires specific studies.
The incidence of imaging abnormalities after the treat-
ment is relatively high in our series. Most authors report
imaging abnormalities in about one third of the patients after
treatment [22, 41, 42]. In a series reported by Hayhurst et
al., it was approaching 50 % of the patients, Nataf et al.
reported even higher rate of parenchymal changes (44.8 %
with T2 hyperintensity, 55.1 % including T1 enhancement
and necrosis) [14, 29]. In our study, the incidence was 60 %
including one asymptomatic radiation necrosis. The doses
applied were within the range reported in other series and
did not appear to be the reason of frequent occurrence of
imaging alterations. Most publications describe experiences
with gamma knife treatment with dose usually specified on
the 50 % isodose. It means that maximal doses that could be
responsible for initiation of radiation damage in the brain are
twice as high as the prescribed ones. Utilization of a linear
accelerator for treatment allows delivery of more homoge-
neous dose than in case of gamma knife, without hot spots
characteristic for the latter and which theoretically could
reduce the risk of radiation-induced damage. Our observa-
tions however do not support this assumption. The occur-
rence of imaging abnormalities also did not appear to be
associated with the volume treated. In other studies, the
irradiated volume was considered to be the main risk factor
for subsequent imaging alterations [14]. Low number of
patients treated precludes the possibility of identification
of risk factors for radiation-induced imaging abnormalities.
On the other hand, high signal intensity on post-treatment
T2 MR images can be related to higher chance of oblitera-
tion [41]. High incidence of imaging alterations along with
high obliteration rate in the current study could support this
assumption. Late adverse effects of the treatment were not
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observed in our series. The occurrence of imaging alterations
according to Yeon et al. was not associated with increased risk
of neuropsychological sequelae [43]. The results of stereotac-
tic irradiation of a large series of patients shown by Nicolato et
al. confirm the safety of this kind of treatment as no adverse
neuropsychological effects or intellectual deterioration were
observed in this group of patients which is an argument in
favor of noninvasive treatment of cerebral AVMs in children
with stereotactic radiosurgery [30]. Nevertheless, the potential
risk of decreased neurocognitive abilities after stereotactic
irradiation, especially in children, should not be neglected.
Consequently, relative high incidence of the imaging altera-
tions in our opinion is the argument for long-term and metic-
ulous observation after the treatment.
Conclusions
Due to small number of patients in our series, we do not
attempt to draw general conclusions. It can be assumed that
stereotactic radiosurgery is an effective method of treatment
for pediatric AVMs. The patients require meticulous follow-
up because of relative high incidence of radiation-induced
imaging and potential risk of late adverse effects of the
treatment. Further studies aiming at elucidation of radiobi-
ological properties of AVMs in pediatric population are
needed in order to establish the most efficient and safe
fractionation regimen. Detailed analysis of the dose–re-
sponse relationship on data pooled from other centers would
probably shed more light on the actual alpha/beta ratio of
pediatric AVMs and perhaps would allow for optimization
of the treatment protocols.
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